Laboratory Biomarkers for Guiding Therapy with Methotrexate in Rheumatoid Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|2|202-211

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.2, 2015-01, pp. : 202-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond methotrexate: biologic therapy in rheumatoid arthritis

By Ostör Andrew J  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 222-226

Royal College Of Physicians

Access to resources Recommend Favorite

Cyclosporine a Pharmacokinetics in Rheumatoid Arthritis Patients After 6 Months of Methotrexate Therapy

By Baraldo M.   Ferraccioli G.   Pea F.   Gremese E.   Furlanut M.  

Pharmacological Research, Vol. 40, Iss. 6, 1999-12 ,pp. : 483-486

Academic Press

Access to resources Recommend Favorite

Sulfasalazine + methotrexate beneficial for rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Methotrexate improves survival in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

An update on methotrexate pharmacogenetics in rheumatoid arthritis

By Ranganathan Prabha  

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 439-451

Future Medicine

Access to resources Recommend Favorite